Publications

Dysregulation of arginase and arginine pathways in neurodegenerative diseases: Metabolic and cellular dysfunction and therapeutic implications

 89
Dysregulation of arginase and arginine pathways in neurodegenerative diseases: Metabolic and cellular dysfunction and therapeutic implications

Tags:

Previous Article

Fibroblast growth factor receptor (FGFR) rearrangements in cancer!

Next Article

Mechanism of lipid-dependent cold sensitivity in a model ion channel

Related Posts

PRDX6 dictates ferroptosis sensitivity by directing cellular selenium utilization

PRDX6 dictates ferroptosis sensitivity by directing cel...

 125

Targeting RhoA nuclear mechanoactivity rejuvenates aged hematopoietic stem cells

Targeting RhoA nuclear mechanoactivity rejuvenates aged...

 50

Lithium deficiency and the onset of Alzheimer’s disease

Lithium deficiency and the onset of Alzheimer’s disease

 257